Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-29

Clinical Trial Update: Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? [Phase 3]

View source ↗

Summary

Phase 3 trial investigating hydroxychloroquine as pre-exposure prophylaxis for healthcare workers exposed to coronavirus; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Megan Landes | Conditions: Pre-Exposure Prophylaxis, Coronavirus | Phase 3 | Status: TERMINATED